Skip to main content
. 2022 Sep 13;7(12):2670–2676. doi: 10.1182/bloodadvances.2022008116

Figure 2.

Figure 2.

Baseline PD-L1 expression and correlation to single-agent pembrolizumab response. (A-C) PD-1 pathway correlates baseline PD-L1/PAX-5 staining by immunohistochemistry (A), PD-L1 H score distribution across a cohort of 29 patients (B), and association between PET responses to single-agent pembrolizumab and PD-L1 H score in baseline biopsy specimens (C).